Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/688163 stock hub

SHA/688163 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/688163is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/688163
In the news

Latest news · SHA/688163

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E69
P25 23.5P50 41.3P75 83.2
ROE4.4
P25 -0.9P50 4.1P75 8.8
ROIC12.5
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/688163 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
205
Groups with data
11
Currency
CNY
Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
China
Country code
CN
Employees
324
Employees Change
-2%
Employees Change Percent
-0.61
Enterprise value
CNY 3.2B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Last refreshed
2026-05-10
Market cap
CNY 4B
Price
CNY 36.94
Price currency
CNY
Rev Per Employee
606,374.72x
Sector
Healthcare
Sic
2836
Symbol
sha/688163
Website
https://www.serum-china.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
1.22%
EV Earnings
66.63x
EV/EBIT
62x
EV/EBITDA
45.32x
EV/FCF
-366.83x
EV/Sales
16.38x
FCF yield
-0.22%
P/B ratio
3.59x
P/E ratio
68.99x
P/S ratio
20.22x
PE Ratio3 Y
45.17x
PE Ratio5 Y
43.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
26.42%
EBITDA Margin
35.83%
Gross margin
77.8%
Gross Profit
CNY 153.8M
Gross Profit Growth
0.83%
Gross Profit Growth Q
2.68%
Gross Profit Growth3 Y
4.01%
Gross Profit Growth5 Y
-0.64%
Net Income
CNY 48.6M
Net Income Growth
4.35%
Net Income Growth Q
-84.91%
Net Income Growth3 Y
-8.41%
Net Income Growth5 Y
-5.87%
Pretax Margin
30.58%
Profit Margin
24.58%
Profit Per Employee
CNY 149,071
ROA
2.88
Roa5y
5.15
ROCE
4.66
ROE
4.39
Roe5y
8.78
ROIC
12.48
Roic5y
20.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr1y
115.74%
Cagr3y
20.21%
EPS Growth
17.81
EPS Growth Q
-66.67
EPS Growth3 Y
-4.69
EPS Growth5 Y
-7.94
OCF Growth
36.35%
OCF Growth3 Y
6.62%
OCF Growth5 Y
-3.16%
Revenue Growth
1.77x
Revenue Growth Q
5.75x
Revenue Growth3 Y
4.49x
Revenue Growth5 Y
1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
CNY 0.17
Assets
CNY 1.2B
Cash
CNY 764.8M
Current Assets
CNY 891.4M
Current Liabilities
CNY 33.8M
Debt
CNY 4.9M
Debt EBITDA
CNY 0.07
Debt Equity
CNY 0
Debt FCF
CNY -0.56
Equity
CNY 1.1B
Liabilities
CNY 41.1M
Long Term Assets
CNY 263M
Long Term Liabilities
CNY 7.4M
Net Cash
CNY 759.8M
Net Cash By Market Cap
CNY 19.01
Net Cash Growth
-4.49%
Net Debt EBITDA
CNY -10.73
Net Debt Equity
CNY -0.68
Tangible Book Value
CNY 1.1B
Tangible Book Value Per Share
CNY 19.23
WACC
7.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
26.4
Inventory Turnover
0.94
Net Working Capital
CNY 93.6M
Quick ratio
24.33
Working Capital
CNY 857.6M
Working Capital Turnover
CNY 0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Buyback Yield
11.43%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
CNY 0.32
Dividend Years
4
Dividend Yield
0.87%
Last Dividend
CNY 0.12
Payout Ratio
71.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
115.63%
200-day SMA
25.12
3Y total return
73.72%
50-day SMA
28.96
50-day SMA vs 200-day SMA
50over200
All Time High
62.99
All Time High Change
-41.36%
All Time High Date
2022-03-11
All Time Low
10.98
All Time Low Change
236.43%
All Time Low Date
2024-02-06
ATR
2.2
Beta
0.57
Beta1y
1.06
Beta2y
0.86
Ch YTD
69.68
High
38.28
High52
42.5
High52 Date
2026-04-23
High52ch
-13.08%
Low
35.15
Low52
17.12
Low52 Date
2025-05-15
Low52ch
115.77%
Ma50ch
27.55%
Price vs 200-day SMA
47.07%
RSI
63.96
RSI Monthly
75.24
RSI Weekly
79.01
Sharpe ratio
2.11x
Sortino ratio
3.95
Total Return
12.29%
Tr YTD
69.68
Tr1m
27.91%
Tr1w
4.5%
Tr3m
44.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
CNY 52.2M
Operating Income Growth
-7.07
Operating Income Growth3 Y
2.91
Operating Income Growth5 Y
-7.79
Operating margin
26.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
43,983,077%
Shares Insiders
34.41%
Shares Institutions
1.79%
Shares Out
108,220,000
Shares Qo Q
-46.02%
Shares Yo Y
-11.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

56
MetricValue
Adjusted FCF
CNY -8.8M
Average Volume
3,458,586x
Bv Per Share
19.63
CAPEX
CNY -78.5M
Ch1m
27.91
Ch1w
4.5
Ch1y
112.3
Ch3m
44.64
Ch3y
62.02
Ch6m
53.41
Change
2.61%
Change From Open
1.26
Close
36
Days Gap
1.33
Depreciation Amortization
18,606,282
Dollar Volume
129,905,789.8
Earnings Date
2026-04-25
EBIT
CNY 52.2M
EBITDA
CNY 70.8M
EPS
CNY 0.54
F Score
5
FCF
CNY -8.8M
FCF EV Yield
-0.27x
FCF Per Share
CNY -0.08
Financing CF
-35,436,877
Fiscal Year End
December
Founded
1,999
Graham Number
15.37743
Graham Upside
-58.37
Income Tax
CNY 11.9M
Investing CF
-332,585,729
Is Primary Listing
1
Last Earnings Date
2026-04-25
Last Report Date
2026-03-31
Lynch Fair Value
CNY 2.68
Lynch Upside
-92.75
Ma150
25.38
Ma150ch
45.52%
Ma20
35.02
Ma20ch
5.48%
Net CF
-298,285,945
Next Earnings Date
2026-08-26
Open
36.48
P OCF Ratio
57.36
Payment Date
2025-09-26
Position In Range
57.19
Ppne
218,092,358
Price Date
2026-05-08
Price EBITDA
CNY 56.44
Ptbv Ratio
3.66
Relative Volume
1.02x
Revenue
197,678,158x
Tax By Revenue
6x
Tax Rate
19.62%
Tr6m
53.41%
Volume
3,516,670
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHA/688163 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.9%
$0.32 annual per share
Payout ratio
+71.3%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
+12.3%
Dividend yield + buyback yield combined
Performance

SHA/688163 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+115.6%
S&P 500 1Y: n/a
3Y total return
+73.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns SHA/688163?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.8%
Share of float held by funds and institutions
Insider ownership
+34.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-11.4%
Negative means the company is buying back shares.
Technical

SHA/688163 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
64.0
Neutral momentum band
Price vs 200-day MA
+47.1%
50/200-day relationship not available
Beta (5Y)
0.57
Less volatile than the market
Sharpe ratio
2.10
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/688163

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688163 stock rating?

sha/688163 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688163 analysis?

The full report lives at /stocks/sha/688163/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688163?

The latest report frames sha/688163 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688163 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.